Drug Chatter -- Tracking biopharma stock chatter

Profile for Cardiome Pharma Corporation (CRME)

« Back to company index

CRME Chatter Timeline

Stock Ticker for CRME

Most Active Tweeters for CRME

UserTweets
@intercooleronli 4
@TickerReport 4
@WKRBNews 3
@emq_news 3
@TheMarketsDaily 3

Recent Tweets for CRME

dakotafinancial @dakotafinancial
Cardiome Pharma Corporation $CRME Rating Reiterated by Canaccord Genuity https://t.co/2XAwH5E4zc
July 19th 2017, 5:07pm
intercooleronli @intercooleronli
Cardiome Pharma Corporation $CRME Upgraded at Zacks Investment Research https://t.co/ukKCMzNnpb
July 18th 2017, 9:07pm
RatingsNetwork @RatingsNetwork
Cardiome Pharma Corporation upgraded by Zacks Investment Research to hold. https://t.co/yd5zZYzQAB $CRME #CRME
July 18th 2017, 8:07pm
TheMarketsDaily @TheMarketsDaily
Cardiome Pharma Corporation $CRME Upgraded to “Hold” at Zacks Investment Research https://t.co/rMUQGERaa9
July 18th 2017, 8:07pm
WKRBNews @WKRBNews
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/UGTSnrx6Fs
July 17th 2017, 4:07pm
SPNewsAnalysis @SPNewsAnalysis
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/oAS2y3Btvo
July 17th 2017, 4:07pm
QLFilings @QLFilings
$CRME filed Form 6-K with the SEC. Most mentioned words: cardiome, aggrastat, ms, eb, oa
July 17th 2017, 1:07pm
StockNewsWires @StockNewsWires
$CRME: CARDIOME PHARMA CORP.: https://t.co/rz2SHDJ807
July 17th 2017, 1:07pm
confcalltran @confcalltran
Cardiome Pharma: News Release Dated July 17, 2017 https://t.co/aNfFHgxKBc $CRME
July 17th 2017, 1:07pm
AlertTrade @AlertTrade
#Upgrades #Downgrades ? $CRME: Canaccord Genuity resumes at Buy https://t.co/ZrA6qE6jQy via ? https://t.co/U5xCBHFNAP
July 17th 2017, 11:07am
firsttomarkets @firsttomarkets
Cardiome Pharma Corp Reiterated Rating by Canaccord Genuity (Ranked 64th) to Buy with $8PT $CRME #CRME https://t.co/hbUaB5p3Lk
July 17th 2017, 11:07am
TheMarketsDaily @TheMarketsDaily
Cardiome Pharma Corporation $CRME Stock Rating Reaffirmed by Canaccord Genuity https://t.co/p62noqlcgR
July 17th 2017, 10:07am
intercooleronli @intercooleronli
Cardiome Pharma Corporation $CRME Earns “Buy” Rating from Canaccord Genuity https://t.co/mPPf6yXdwH
July 17th 2017, 10:07am
sitifatimahnet @sitifatimahnet
Canadian regulator OK's high-dose bolus regimen of Cardiome's Aggrastat https://t.co/30acWs3qN2 $CRME #sitifatimah #malaysia #financialpla…
July 17th 2017, 10:07am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Canadian regulator OK's high-dose bolus regimen of Cardiome's Aggrastat https://t.co/ZeKSLulifx $CRME
July 17th 2017, 10:07am
MarketCurrents @MarketCurrents
Canadian regulator OK's high-dose bolus regimen of Cardiome's Aggrastat https://t.co/LcdKunU5Wy $CRME
July 17th 2017, 10:07am
Briefingcom @Briefingcom
$CRME: Canaccord Genuity resumes at Buy
July 17th 2017, 10:07am
biotechtoreador @biotechtoreador
$CRME is another bioturd I can't believe still exists. #btechcockroaches https://t.co/k6irIWu3eV
July 17th 2017, 10:07am
Briefingcom @Briefingcom
$CRME: Cardiome Pharma announces that the Therapeutic Products Directorate of Health Canada has approved the... https://t.co/nKsyweTWvh
July 17th 2017, 10:07am
StockNewsNow @StockNewsNow
$CRME $COM.TO Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen https://t.co/QTCzL4pAIC
July 17th 2017, 9:07am
HoganMullally @HoganMullally
$CRME $COM.TO receives Canadian approval for AGGRASTAT HDB
July 17th 2017, 9:07am
newswithvalue @newswithvalue
$CRME $HTA: Premarket analyst action – healthcare: https://t.co/kSqaDbdBMJ
July 17th 2017, 8:07am
jfais20 @jfais20
$CRME Buy at Canaccord $ PT, attractive top line growth, unique business model, upside future biz dev + Brinavess commercialization
July 17th 2017, 8:07am
emq_news @emq_news
Cardiome Pharma Corporation $CRME Stock Rating Reaffirmed by Canaccord Genuity https://t.co/ZDZHFKmQsh
July 17th 2017, 8:07am
RatingsNetwork @RatingsNetwork
Cardiome Pharma Corporation's buy rating reiterated at Canaccord Genuity. $8.00 PT. https://t.co/epiztd8uVA $CRME #CRME
July 17th 2017, 8:07am
newswithvalue @newswithvalue
$CRME: Cardiome Announces Health Canada Approval of AGGRASTAT …: https://t.co/mPBpFIlLVi
July 17th 2017, 8:07am
newswelldone @newswelldone
$CRME: Cardiome Pharma (CRME) Receives Health Canada Approval of …: https://t.co/PK1R8fSlwc
July 17th 2017, 8:07am
biostockinfo @biostockinfo
RT @BioStocks: $CRME initiated at Buy at Canaccord. PT $8
July 17th 2017, 8:07am
ZoZoStockwatch @ZoZoStockwatch
$CRME Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen
July 17th 2017, 8:07am
tickerws @tickerws
Canaccord Genuity assumes $CRME at Buy https://t.co/wlPEL4ws0j
July 17th 2017, 8:07am
ARatings @ARatings
Canaccord Genuity Assigns a Buy Rating on Cardiome Pharma Corp $CRME https://t.co/VmalM4bxAH
July 17th 2017, 7:07am
BioStocks @BioStocks
$CRME initiated at Buy at Canaccord. PT $8
July 17th 2017, 7:07am
AnalystWire @AnalystWire
UPDATE: Canaccord Genuity Assumes Cardiome Pharma $CRME at Buy https://t.co/MzEeBzbuVW
July 17th 2017, 7:07am
AnalystWire @AnalystWire
Canaccord Genuity Assumes Cardiome Pharma $CRME at Buy https://t.co/MzEeBzbuVW
July 17th 2017, 5:07am
dailymailtimes @dailymailtimes
Cardiome Pharma Corporation $CRME Expected to Post Quarterly Sales of $6.97 Million https://t.co/Y0pCw1jeLA
July 15th 2017, 5:07am
WKRBNews @WKRBNews
Cardiome Pharma Corporation $CRME Cut to “Sell” at Zacks Investment Research https://t.co/q3ulF7uT8i
July 14th 2017, 5:07pm
WKRBNews @WKRBNews
Cardiome Pharma Corporation $CRME Cut to “Sell” at Zacks Investment Research https://t.co/cEV8ArWH5L
July 14th 2017, 5:07pm
storminvestor @storminvestor
Somewhat Critical Media Coverage Unlikely to Impact Cardiome Pharma Corporation $CRME Share Price https://t.co/k8RPFm8QzY
July 14th 2017, 11:07am
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/nZ4uZu20L7
July 13th 2017, 7:07am
TickerReport @TickerReport
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/0vTnUz3tsI
July 13th 2017, 2:07am
emq_news @emq_news
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/gKtJG1vqlW
July 13th 2017, 2:07am
TickerReport @TickerReport
Zacks Investment Research Downgrades Cardiome Pharma Corporation $CRME to Sell https://t.co/o5sfn75wdB
July 13th 2017, 2:07am
midetimes @midetimes
Cardiome Pharma Corporation $CRME Downgraded to “Sell” at Zacks Investment Research https://t.co/rcNNsp2grR
July 12th 2017, 7:07pm
chaffeybreeze @chaffeybreeze
Cardiome Pharma Corporation $CRME Downgraded by Zacks Investment Research to “Sell” https://t.co/3vouW6JSEW
July 11th 2017, 9:07pm
IRAMarketReport @IRAMarketReport
Cardiome Pharma Corporation $CRME Downgraded by Zacks Investment Research to “Sell” https://t.co/9d45vYJAp5
July 11th 2017, 9:07pm
intercooleronli @intercooleronli
Cardiome Pharma Corporation $CRME Cut to “Sell” at Zacks Investment Research https://t.co/7m63xJT6X0
July 11th 2017, 9:07pm
dailypoliticaln @dailypoliticaln
Cardiome Pharma Corporation $CRME Downgraded by Zacks Investment Research to “Sell” https://t.co/QT4tqXb6UL
July 11th 2017, 9:07pm
RatingsNetwork @RatingsNetwork
Cardiome Pharma Corporation downgraded by Zacks Investment Research to sell. https://t.co/AWGInq7q39 $CRME #CRME
July 11th 2017, 9:07pm
dakotafinancial @dakotafinancial
Cardiome Pharma Corporation $CRME Receives Consensus Rating of “Buy” from Analysts https://t.co/iiYT4E0zsf
July 8th 2017, 6:07pm
TickerReport @TickerReport
Brokerages Expect Cardiome Pharma Corporation $CRME Will Announce Earnings of -$0.18 Per Share https://t.co/qGP6G8i3FB
July 8th 2017, 2:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.